GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $113K invested in Galmed Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$71.1K
2
+$5.97K
3
+$3.33K

Top Sellers

1
-$7.84K
2
-$7.71K
3
-$1.64K
4
UBS Group
UBS Group
Switzerland
-$552
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$83.1K
2
$13.5K
3
$9.96K
4
$3.33K
5
$2.84K
6
$77
7
$56
8
$46
9
$14
10
$6
11
$2
12
–